Ingalls & Snyder LLC Immuno Precise Antibodies Ltd. Transaction History
Ingalls & Snyder LLC
- $2.33 Billion
- Q2 2024
A detailed history of Ingalls & Snyder LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 1,295,441 shares of IPA stock, worth $518,176. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,295,441
Previous 1,288,535
0.54%
Holding current value
$518,176
Previous $1.96 Million
33.23%
% of portfolio
0.06%
Previous 0.09%
Shares
15 transactions
Others Institutions Holding IPA
# of Institutions
22Shares Held
1.66MCall Options Held
14.1KPut Options Held
6.9K-
Jim Simons Renaissance Technologies LLC | New York, Ny63.9KShares$25,5640.0% of portfolio
-
Bank Of Montreal Toronto, A655.9KShares$22,3420.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$20,2920.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$16,4800.0% of portfolio
-
Federation Des Caisses Desjardins Du Quebec Levis, A827KShares$10,8130.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $9.93M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...